Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas

被引:12
作者
Bogusiewicz, Michal
Semczuk, Andrzej
Gogacz, Marek
Skomra, Danuta
Jakowicki, Jerzy A.
Rechberger, Tomasz
机构
[1] Tech Univ Lublin, Sch Med, Dept Gynecol 2, PL-20954 Lublin, Poland
[2] Tech Univ Lublin, Sch Med, Dept Pathol, PL-20954 Lublin, Poland
关键词
leptin; leptin receptor; PI3-K/Akt kinase pathway; BMI; endometrial cancer;
D O I
10.1016/j.canlet.2005.06.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A number of studies published recently focused on the putative role of leptin in the pathogenesis of various primary human malignancies. Current study was aimed at investigating ObR, P13-kinase, phospho-Akt kinase and PTEN proteins expression in forty-five primary human endometrioid-type endometrial carcinomas (EC). ObR immunostaining was detected in 21 of 45 (47%) ECs, presented in almost 60% of well- and moderately-differentiated tumors compared to only 17% of poorly-differentiated neoplasms (P < 0.05). Semi-quantitative histological score (H-score) ObR values were inversely correlated with patients' body mass index (R= -0.35; P=0.019). ObR expression was significantly higher in normal weight compared to overweight and obese patients (P=0.024). All slides displayed intense P13-kinase immunoreactivity, whereas phospho-Akt kinase expression was reported in 96% (43 out of 45) cases. Fifteen (33%) ECs were negative for PTEN expression, nine (20%) showed heterogeneous immunostaining pattern, whereas 21 (47%) were PTEN-positive. There was a trend towards a higher phospho-Akt kinase intensity immunostaining in PTEN-negative compared to PTEN-positive cases, but the difference was not significant. There was no significant association between each P13-K/Akt signaling pathway proteins immunostaining in endometrioid-type ECs. In conclusion, ObR expression is associated with histological grading and the weight of women affected by EC. The components of P13-K/Akt kinase signaling pathway are expressed in most of the primary endometrioid-type endometrial neoplasms. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 37 条
[11]   Akt/PKB signaling mechanisms in cancer and chemoresistance [J].
Kim, D ;
Dan, HC ;
Park, S ;
Yang, L ;
Liu, QY ;
Kaneko, S ;
Ning, JY ;
He, LL ;
Yang, H ;
Sun, M ;
Nicosia, SV ;
Cheng, JQ .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :975-987
[12]   Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias [J].
Konopka, B ;
Paszko, Z ;
Janiec-Jankowska, A ;
Goluda, M .
CANCER LETTERS, 2002, 178 (01) :43-51
[13]   BODY-MASS AT DIFFERENT AGES AND SUBSEQUENT ENDOMETRIAL CANCER RISK [J].
LEVI, F ;
LAVECCHIA, C ;
NEGRI, E ;
PARAZZINI, F ;
FRANCESCHI, S .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (04) :567-571
[14]  
Markowska A, 2004, EUR J GYNAECOL ONCOL, V25, P192
[15]  
MIKUTA JJ, 1995, CANCER, V76, P2041, DOI 10.1002/1097-0142(19951115)76:10+<2041::AID-CNCR2820761322>3.0.CO
[16]  
2-Z
[17]   bcl-2 protein expression in endometrial carcinoma:: the lack of correlation with p53 [J].
Miturski, R ;
Semczuk, A ;
Tomaszewski, J ;
Jakowicki, J .
CANCER LETTERS, 1998, 133 (01) :63-69
[18]  
MITURSKI R, 2003, INT J MOL MED, V12, P396
[19]   Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers [J].
Mutter, GL ;
Lin, MC ;
Fitzgerald, JT ;
Kum, JB ;
Baak, JPA ;
Lees, JA ;
Weng, LP ;
Eng, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (11) :924-931
[20]  
NERI LM, 1994, CELL MOL BIOL, V40, P619